Clinical Trial Update: Tolerability, Pharmacokinetics, and Efficacy of APD371 in Participants With Crohn's Disease Experiencing Abdominal Pain [Phase 2]

View source ↗

Summary

Phase 2 trial update on tolerability, pharmacokinetics, and efficacy of APD371 in Crohn's disease patients with abdominal pain; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• APD371

Snippet

Sponsor: Arena Pharmaceuticals | Conditions: Crohn's Disease, Abdominal Pain | Phase 2 | Status: COMPLETED | Results posted: 2021-11-02